United States Wound Care Management Investment Opportunities, Analysis and Forecasts to 2015

Content

• 1 Table of Contents
  • 1.1 1.2 2 Introduction
  • 2.1 What Is This Report About?
• 3 Definitions of Markets Covered in This Report
  • 3.1 Wound Care Management
  • 3.2 Advanced Wound Management
    • 3.2.1 Alginates
    • 3.2.2 Collagens
    • 3.2.3 Foams
    • 3.2.4 Hydrocolloids
    • 3.2.5 Hydrofibres
    • 3.2.6 Hydrogels
    • 3.2.7 Negative Pressure Wound Therapy (NPWT)
    • 3.2.8 Semi-Permeable Films
  • 3.3 Compression Therapy
  • 3.4 Ostomy
  • 3.5 Traditional Wound Management
  • 3.6 Wound Closure Devices
    • 3.6.1 Skin Closure Devices
    • 3.6.2 Tissue Sealants
• 4 Healthcare Sector Review
  • 4.1 Healthcare Expenditure
  • 4.2 Healthcare Infrastructure
    • 4.2.1 Healthcare Personnel Data
    • 4.2.2 Healthcare Facilities Data
  • 4.3 United States Healthcare Trade Statistics
• 5 Regulation System
  • 5.1 Regulation System
  • 5.2 Medical Equipment Approval Process
    • 5.2.1 Pre-market Approval Process
    • 5.2.2 Intended use and Indications for use
    • 5.2.3 Predicate Device
    • 5.2.4 Safe and Effective
    • 5.2.5 Other Category Devices
    • 5.2.6 Post-Market Approval Process
    • 5.2.7 Compliance and Enforcement
    • 5.2.8 Registration Fee
    • 5.2.9 Approval Time
• 6 Pricing and Reimbursement
  • 6.1 Government Policies
  • 6.2 Private Insurance
  • 6.3 Diagnosis Related Groups (DRG)
• 7 Distribution Structure
  • 7.1 Distribution Structure
• 8 Wound Care Management In United States
  • 8.1 Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015
  • 8.2 Wound Care Management, United States, Overall Revenue ($ mn), 2000-2015
  • 8.3 Wound Care Management, United States, Category Volume (Units), 2000-2015
  • 8.4 Wound Care Management, United States, Company Share (2006-2007)
• 9 Advanced Wound Management In United States
  • 9.1 Advanced Wound Management Overall Revenue (2000-2015)
  • 9.2 Advanced Wound Management Overall Volume (2000-2015)
  • 9.3 Advanced Wound Management Average Price (2000-2015)
  • 9.4 Advanced Wound Management Distribution Share (2007-2008)
  • 9.5 Advanced Wound Management, United States, Company Share (2006-2007)
• 10 Compression Therapy In United States
  • 10.1 Compression Therapy Overall Revenue (2000-2015)
  • 10.2 Compression Therapy Overall Volume (2000-2015)
  • 10.3 Compression Therapy Average Price (2000-2015)
  • 10.4 Compression Therapy Distribution Share (2007-2008)
  • 10.5 Compression Therapy, United States, Company Share (2006-2007)
• 11 Ostomy In United States
  • 11.1 Ostomy Overall Revenue (2000-2015)
  • 11.2 Ostomy Overall Volume (2000-2015)
  • 11.3 Ostomy Average Price (2000-2015)
  • 11.4 Ostomy Distribution Share (2007-2008)
  • 11.5 Ostomy, United States, Company Share (2006-2007)
• 12 Traditional Wound Management In United States
  • 12.1 Traditional Wound Management Overall Revenue (2000-2015)
  • 12.2 Traditional Wound Management Overall Volume (2000-2015)
  • 12.3 Traditional Wound Management Average Price (2000-2015)
  • 12.4 Traditional Wound Management Distribution Share (2007-2008)
  • 12.5 Traditional Wound Management, United States, Company Share (2006-2007)
• 13 Wound Closure Devices In United States
  • 13.1 Wound Closure Devices Overall Revenue (2000-2015)
  • 13.2 Wound Closure Devices Overall Volume (2000-2015)
  • 13.3 Wound Closure Devices Average Price (2000-2015)
  • 13.4 Wound Closure Devices Distribution Share (2007-2008)
  • 13.5 Wound Closure Devices, United States, Company Share (2006-2007)
• 14 Overview of Key Companies in United States Wound Care Management Market
  • 14.1 Baxter International Inc
    • 14.1.1 Company Overview
    • 14.1.2 Value Chain Analysis
      • 14.1.2.1 Manufacturing
      • 14.1.2.2 Product Development
      • 14.1.2.3 Sales and Marketing
  • 14.2 Covidien Ltd
    • 14.2.1 Company Overview
    • 14.2.2 Value Chain Analysis
      • 14.2.2.1 Manufacturing
      • 14.2.2.2 Product Development
      • 14.2.2.3 Sales and Marketing
  • 14.3 3M Company
    • 14.3.1 Company Overview
  • 14.4 Ethicon, Inc
    • 14.4.1 Company Overview
    • 14.4.2 Ethicon, Inc. Pipeline Products
      • 14.4.2.1 Ethicon, Inc. Pipeline Products By Equipment Type
      • 14.4.2.2 Ethicon, Inc. Pipeline Products By Development Stage
      • 14.4.2.3 Ethicon, Inc. Pipeline Products By Therapy Area
      • 14.4.2.4 Ethicon, Inc. Pipeline Products By Clinical Trials
  • 14.5 Smith & Nephew Plc
    • 14.5.1 Company Overview
    • 14.5.2 Value Chain Analysis
      • 14.5.2.1 Manufacturing
      • 14.5.2.2 Product Development
      • 14.5.2.3 Sales and Marketing
    • 14.5.3 Smith & Nephew Plc Pipeline Products
      • 14.5.3.1 Smith & Nephew Plc Pipeline Products By Equipment Type
      • 14.5.3.2 Smith & Nephew Plc Pipeline Products By Development Stage
      • 14.5.3.3 Smith & Nephew Plc Pipeline Products By Therapy Area
      • 14.5.3.4 Smith & Nephew Plc Pipeline Products By News Summary
  • 14.6 ConvaTec
    • 14.6.1 Company Overview
  • 14.7 Johnson & Johnson
    • 14.7.1 Company Overview
    • 14.7.2 Value Chain Analysis
      • 14.7.2.1 Manufacturing
      • 14.7.2.2 Product Development
      • 14.7.2.3 Sales and Marketing
  • 14.8 Coloplast A/S
    • 14.8.1 Company Overview
    • 14.8.2 Value Chain Analysis
      • 14.8.2.1 Manufacturing
      • 14.8.2.2 Product Development
      • 14.8.2.3 Sales and Marketing
  • 14.9 Kinetic Concepts, Inc
    • 14.9.1 Company Overview
    • 14.9.2 Value Chain Analysis
      • 14.9.2.1 Manufacturing
      • 14.9.2.2 Product Development
      • 14.9.2.3 Sales and Marketing
    • 14.9.3 Kinetic Concepts, Inc. Pipeline Products
      • 14.9.3.1 Kinetic Concepts, Inc. Pipeline Products By Equipment Type
      • 14.9.3.2 Kinetic Concepts, Inc. Pipeline Products By Development Stage
      • 14.9.3.3 Kinetic Concepts, Inc. Pipeline Products By Therapy Area
      • 14.9.3.4 Kinetic Concepts, Inc. Pipeline Products By Clinical Trials
      • 14.9.3.5 Kinetic Concepts, Inc. Pipeline Products By News Summary
  • 14.10 Advanced Medical Solutions Group plc
    • 14.10.1 Company Overview
    • 14.10.2 Value Chain Analysis
      • 14.10.2.1 Manufacturing
      • 14.10.2.2 Product Development
      • 14.10.2.3 Sales and Marketing
    • 14.10.3 Advanced Medical Solutions Group Plc Pipeline Products
      • 14.10.3.1 Advanced Medical Solutions Group Plc Pipeline Products By Equipment Type
      • 14.10.3.2 Advanced Medical Solutions Group Plc Pipeline Products By Development Stage
      • 14.10.3.3 Advanced Medical Solutions Group Plc Pipeline Products By Therapy Area
  • 14.11 HARTMANN GROUP
    • 14.11.1 Company Overview
    • 14.11.2 Value Chain Analysis
      • 14.11.2.1 Manufacturing
      • 14.11.2.2 Product Development
      • 14.11.2.3 Sales and Marketing
  • 14.12 BSN medical GmbH
    • 14.12.1 Company Overview
  • 14.13 Hollister Incorporated
    • 14.13.1 Company Overview
  • 14.14 Julius Zorn, Inc
    • 14.14.1 Company Overview
  • 14.15 SIGVARIS, Inc
    • 14.15.1 Company Overview
  • 14.16 AMD-Ritmed Inc
    • 14.16.1 Company Overview
  • 14.17 Integra LifeSciences Holdings Corporation
    • 14.17.1 Company Overview
    • 14.17.2 Value Chain Analysis
      • 14.17.2.1 Manufacturing
      • 14.17.2.2 Product Development
      • 14.17.2.3 Sales and Marketing
  • 14.18 Derma Sciences, Inc
    • 14.18.1 Company Overview
    • 14.18.2 Derma Sciences, Inc. Pipeline Products
      • 14.18.2.1 Derma Sciences, Inc. Pipeline Products By Equipment Type
      • 14.18.2.2 Derma Sciences, Inc. Pipeline Products By Development Stage
      • 14.18.2.3 Derma Sciences, Inc. Pipeline Products By Therapy Area
      • 14.18.2.4 Derma Sciences, Inc. Pipeline Products By News Summary
  • 14.19 Lifecore Biomedical, Inc
    • 14.19.1 Company Overview
    • 14.19.2 Lifecore Biomedical, Inc. Pipeline Products
      • 14.19.2.1 Lifecore Biomedical, Inc. Pipeline Products By Equipment Type
      • 14.19.2.2 Lifecore Biomedical, Inc. Pipeline Products By Development Stage
      • 14.19.2.3 Lifecore Biomedical, Inc. Pipeline Products By Therapy Area
      • 14.19.2.4 Lifecore Biomedical, Inc. Pipeline Products By News Summary
  • 14.20 Covalent Medical, Inc
    • 14.20.1 Company Overview
    • 14.20.2 Covalent Medical, Inc. Pipeline Products
      • 14.20.2.1 Covalent Medical, Inc. Pipeline Products by Equipment Type
      • 14.20.2.2 Covalent Medical, Inc. Pipeline Products By Development Stage
      • 14.20.2.3 Covalent Medical, Inc. Pipeline Products By Therapy Area
  • 14.21 FzioMed, Inc
    • 14.21.1 Company Overview
    • 14.21.2 FzioMed, Inc. Pipeline Products
      • 14.21.2.1 FzioMed, Inc. Pipeline Products By Equipment Type
      • 14.21.2.2 FzioMed, Inc. Pipeline Products By Development Stage
      • 14.21.2.3 FzioMed, Inc. Pipeline Products By Therapy Area
      • 14.21.2.4 FzioMed, Inc. Pipeline Products By Clinical Trials
      • 14.21.2.5 FzioMed, Inc. Pipeline Products By News Summary
  • 14.22 IYIA Technologies, Inc
    • 14.22.1 Company Overview
    • 14.22.2 IYIA Technologies, Inc. Pipeline Products
      • 14.22.2.1 IYIA Technologies, Inc. Pipeline Products By Equipment Type
      • 14.22.2.2 IYIA Technologies, Inc. Pipeline Products By Development Stage
      • 14.22.2.3 IYIA Technologies, Inc. Pipeline Products By Therapy Area
      • 14.22.2.4 IYIA Technologies, Inc. Pipeline Products By Clinical Trials
      • 14.22.2.5 IYIA Technologies, Inc. Pipeline Products By News Summary
  • 14.23 ThermoGenesis Corp
    • 14.23.1 Company Overview
    • 14.23.2 ThermoGenesis Corp. Pipeline Products
      • 14.23.2.1 ThermoGenesis Corp. Pipeline Products By Equipment Type
      • 14.23.2.2 ThermoGenesis Corp. Pipeline Products By Development Stage
      • 14.23.2.3 ThermoGenesis Corp. Pipeline Products By Therapy Area
      • 14.23.2.4 ThermoGenesis Corp. Pipeline Products By Clinical Trials
      • 14.23.2.5 ThermoGenesis Corp. Pipeline Products By News Summary
  • 14.24 CSMG Technologies, Inc
    • 14.24.1 Company Overview
    • 14.24.2 CSMG Technologies, Inc. Pipeline Products
      • 14.24.2.1 CSMG Technologies, Inc. Pipeline Products By Equipment Type
      • 14.24.2.2 CSMG Technologies, Inc. Pipeline Products By Development Stage
      • 14.24.2.3 CSMG Technologies, Inc. Pipeline Products By Therapy Area
  • 14.25 Molnlycke Health Care AB
    • 14.25.1 Company Overview
  • 14.26 DeRoyal Industries, Inc
    • 14.26.1 Company Overview
  • 14.27 Tyco Healthcare/Kendall
    • 14.27.1 Company Overview
  • 14.28 Southwest Technologies, Inc
    • 14.28.1 Company Overview
  • 14.29 TEI Biosciences Inc
    • 14.29.1 Company Overview
  • 14.30 Neuro Resource Group, Inc
    • 14.30.1 Company Overview
• 15 Financial Deals Landscape
  • 15.1 Acquisition
    • 15.1.1 Applied Nanoscience Terminates Acquisition Of Emergency Filtration Products
    • 15.1.2 Moog Acquires Ethox International
    • 15.1.3 Johnson & Johnson Acquires Omrix Biopharmaceuticals
    • 15.1.4 Filtrona Acquires Lendell Manufacturing
  • 15.2 Partnerships
    • 15.2.1 ACell Signs An Agreement With Medline Industries
    • 15.2.2 HyperBranch Medical Technology Enters Into An Agreement With BD
    • 15.2.3 Ivivi Technologies Signs An Agreement With Recovercare
    • 15.2.4 ConvaTec Enters Into An Agreement With Boehringer Wound Systems
• 16 Recent Developments
  • 16.1 Strategy and Business Planning
    • 16.1.1 Mar 30, 2009: KCI Announces Cost Reduction Initiatives
    • 16.1.2 Feb 02, 2009: ConvaTec Plans To Expand In Greensboro
    • 16.1.3 Oct 21, 2008: Smith & Nephew to Open New Biologics & Spine Business Unit
    • 16.1.4 Oct 16, 2008: Pegasus Biologics Announces Facility Expansion
  • 16.2 Legal and Regulatory
    • 16.2.1 Feb 02, 2009: KCI Says Court Again Affirms Patents as Valid
    • 16.2.2 Dec 18, 2008: KCI Files Patent Violation Lawsuit Against Convatec and Boehringer
    • 16.2.3 Dec 11, 2008: KCI Files New Patent Lawsuit against Smith & Nephew
  • 16.3 Government and Public Interest
    • 16.3.1 Mar 23, 2009: CMS Considers HHS Recommendations on Payments for NPWT Pumps
  • 16.4 Product Approvals
    • 16.4.1 Feb 26, 2009: Quick-Med Technologies Receives FDA Clearance For NIMBUS
    • 16.4.2 Jan 07, 2009: Adhezion Biomedical Announces 510(K) Clearance For SurgiSeal
    • 16.4.3 Nov 25, 2008: KCI's LifeCell Granted CE Mark For Its Strattice Reconstructive Tissue Matrix
    • 16.4.4 Nov 13, 2008: Wound Management Technologies Announces FDA 510k Clearance Of Collagen Technology
    • 16.4.5 Oct 14, 2008: KCI Receives FDA Clearance For Its LifeCell Tissue Matrix For The Management Of Wounds Utilizing Proprietary Strattice Technology
• 17 Appendix
  • 17.1 Global Markets Direct Research Methodology
  • 17.2 Coverage
  • 17.3 Secondary Research
  • 17.4 Primary Research
  • 17.5 Models
  • 17.6 Forecasts
  • 17.7 Expert Panel Validation
  • 17.8 Currency Conversion
  • 17.9 Contact Us
  • 17.10 Disclaimer
• 1.1 List of Tables
  • Table 1: United States Healthcare Expenditure, 2003-2010
  • Table 2: United States Healthcare Expenditure by Age (per person), 2000-2003
  • Table 3: United States Healthcare Expenditure by Sex (per person), 2000-2003
  • Table 4: United States Healthcare Expenditure by Race (per person), 2000-2003
  • Table 5: United States Personal Healthcare Expenditure by Type, 2000-2004
  • Table 6: United States Personal Healthcare Expenditure by Source, 2000-2004
  • Table 7: Total Number of Doctors in the United States, 2003-2010
  • Table 8: Number of Doctors by Specialty in the United States, 2003-2010
  • Table 9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004
  • Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.)
  • Table 11: Total Hospitals in the United States, 2000-2004
  • Table 12: Community Hospitals by Number of Beds in the United States, 2000-2004
  • Table 13: Number of Hospital Beds in the United States, 2000-2004
  • Table 14: Number of Hospital Beds by Range in the United States, 2000-2004
  • Table 15: United States Healthcare Trade Statistics, 2001-2006
  • Table 16: Medical Equipment Registration Fee in United States, 2007
  • Table 17: Medical Device Approval Time in United States, 2004
  • Table 18: Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015
  • Table 19: Wound Care Management, United States, Overall Revenue ($ mn), 2000-2015
  • Table 20: Wound Care Management, United States, Cross-Category Analysis, 2000-2015
  • Table 21: Wound Care Management, United States, Overall Revenue ($ mn), Historic, 2000-2008
  • Table 22: Wound Care Management, United States, Overall Revenue ($ mn), Forecast, 2008-2015
  • Table 23: Wound Care Management, United States, Category Volume (Units), 2000-2015
  • Table 24: Wound Care Management, United States, Category Volume (Units), Historic, 2000-2008
  • Table 25: Wound Care Management, United States, Category Volume (Units), Forecast, 2008-2015
  • Table 26: Wound Care Management, United States, Company Share by Revenue ($ mn), 2006-2007
  • Table 27: Advanced Wound Management, United States, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Table 28: Advanced Wound Management, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Table 29: Advanced Wound Management, United States, Volume (Units) by Segment, Historic, 2000-2008
  • Table 30: Advanced Wound Management, United States, Volume (Units) by Segment, Forecast, 2008-2015
  • Table 31: Advanced Wound Management, United States, Average Price ($), Historic, 2000-2008
  • Table 32: Advanced Wound Management, United States, Average Price ($), Forecast, 2008-2015
  • Table 33: Advanced Wound Management, United States, Distribution Share by Revenue ($mn), 2007-2008
  • Table 34: Advanced Wound Management, United States, Company Share by Revenue ($ mn), 2006-2007
  • Table 35: Compression Therapy, United States, Revenue ($ mn), Historic, 2000-2008
  • Table 36: Compression Therapy, United States, Revenue ($ mn), Forecast, 2008-2015
  • Table 37: Compression Therapy, United States, Volume (Units), Historic, 2000-2008
  • Table 38: Compression Therapy, United States, Volume (Units), Forecast, 2008-2015
  • Table 39: Compression Therapy, United States, Average Price ($), Historic, 2000-2008
  • Table 40: Compression Therapy, United States, Average Price ($), Forecast, 2008-2015
  • Table 41: Compression Therapy, United States, Distribution Share by Revenue ($mn), 2007-2008
  • Table 42: Compression Therapy, United States, Company Share by Revenue ($ mn), 2006-2007
  • Table 43: Ostomy, United States, Revenue ($ mn), Historic, 2000-2008
  • Table 44: Ostomy, United States, Revenue ($ mn), Forecast, 2008-2015
  • Table 45: Ostomy, United States, Volume (Units), Historic, 2000-2008
  • Table 46: Ostomy, United States, Volume (Units), Forecast, 2008-2015
  • Table 47: Ostomy, United States, Average Price ($), Historic, 2000-2008
  • Table 48: Ostomy, United States, Average Price ($), Forecast, 2008-2015
  • Table 49: Ostomy, United States, Distribution Share by Revenue ($mn), 2007-2008
  • Table 50: Ostomy, United States, Company Share by Revenue ($ mn), 2006-2007
  • Table 51: Traditional Wound Management, United States, Revenue ($ mn), Historic, 2000-2008
  • Table 52: Traditional Wound Management, United States, Revenue ($ mn), Forecast, 2008-2015
  • Table 53: Traditional Wound Management, United States, Volume (Units), Historic, 2000-2008
  • Table 54: Traditional Wound Management, United States, Volume (Units), Forecast, 2008-2015
  • Table 55: Traditional Wound Management, United States, Average Price ($), Historic, 2000-2008
  • Table 56: Traditional Wound Management, United States, Average Price ($), Forecast, 2008-2015
  • Table 57: Traditional Wound Management, United States, Distribution Share by Revenue ($mn), 2007-2008
  • Table 58: Traditional Wound Management, United States, Company Share by Revenue ($ mn), 2006-2007
  • Table 59: Wound Closure Devices, United States, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Table 60: Wound Closure Devices, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Table 61: Wound Closure Devices, United States, Volume (Units) by Segment, Historic, 2000-2008
  • Table 62: Wound Closure Devices, United States, Volume (Units) by Segment, Forecast, 2008-2015
  • Table 63: Wound Closure Devices, United States, Average Price ($), Historic, 2000-2008
  • Table 64: Wound Closure Devices, United States, Average Price ($), Forecast, 2008-2015
  • Table 65: Wound Closure Devices, United States, Distribution Share by Revenue ($mn), 2007-2008
  • Table 66: Wound Closure Devices, United States, Company Share by Revenue ($ mn), 2006-2007
  • Table 67: Ethicon, Inc. Pipeline Products by Equipment Type
  • Table 68: Ethicon, Inc. Pipeline Products By Development Stage
  • Table 69: Ethicon, Inc. Pipeline Products By Therapy Area
  • Table 70: Ethicon, Inc. Pipeline Products By Clinical Trials
  • Table 71: Smith & Nephew Plc Pipeline Products by Equipment Type
  • Table 72: Smith & Nephew Plc Pipeline Products By Development Stage
  • Table 73: Smith & Nephew Plc Pipeline Products By Therapy Area
  • Table 74: Smith & Nephew Plc Pipeline Products By News Summary
  • Table 75: Kinetic Concepts, Inc. Pipeline Products by Equipment Type
  • Table 76: Kinetic Concepts, Inc. Pipeline Products By Development Stage
  • Table 77: Kinetic Concepts, Inc. Pipeline Products By Therapy Area
  • Table 78: Kinetic Concepts, Inc. Pipeline Products By Clinical Trials
  • Table 79: Kinetic Concepts, Inc. Pipeline Products By News Summary
  • Table 80: Advanced Medical Solutions Group Plc Pipeline Products by Equipment Type
  • Table 81: Advanced Medical Solutions Group Plc Pipeline Products By Development Stage
  • Table 82: Advanced Medical Solutions Group Plc Pipeline Products By Therapy Area
  • Table 83: Derma Sciences, Inc. Pipeline Products by Equipment Type
  • Table 84: Derma Sciences, Inc. Pipeline Products By Development Stage
  • Table 85: Derma Sciences, Inc. Pipeline Products By Therapy Area
  • Table 86: Derma Sciences, Inc. Pipeline Products By News Summary
  • Table 87: Lifecore Biomedical, Inc. Pipeline Products by Equipment Type
  • Table 88: Lifecore Biomedical, Inc. Pipeline Products By Development Stage
  • Table 89: Lifecore Biomedical, Inc. Pipeline Products By Therapy Area
  • Table 90: Lifecore Biomedical, Inc. Pipeline Products By News Summary
  • Table 91: Covalent Medical, Inc. Pipeline Products by Equipment Type
  • Table 92: Covalent Medical, Inc. Pipeline Products By Development Stage
  • Table 93: Covalent Medical, Inc. Pipeline Products By Therapy Area
  • Table 94: FzioMed, Inc. Pipeline Products by Equipment Type
  • Table 95: FzioMed, Inc. Pipeline Products By Development Stage
  • Table 96: FzioMed, Inc. Pipeline Products By Therapy Area
  • Table 97: FzioMed, Inc. Pipeline Products By Clinical Trials
  • Table 98: FzioMed, Inc. Pipelinee Products By News Summary
  • Table 99: IYIA Technologies, Inc. Pipeline Products by Equipment Type
  • Table 100: IYIA Technologies, Inc. Pipeline Products By Development Stage
  • Table 101: IYIA Technologies, Inc. Pipeline Products By Therapy Area
  • Table 102: IYIA Technologies, Inc. Pipeline Products By Clinical Trials
  • Table 103: IYIA Technologies, Inc. Pipeline Products By News Summary
  • Table 104: ThermoGenesis Corp. Pipeline Products by Equipment Type
  • Table 105: ThermoGenesis Corp. Pipeline Products By Development Stage
  • Table 106: ThermoGenesis Corp. Pipeline Products By Therapy Area
  • Table 107: ThermoGenesis Corp. Pipeline Products By Clinical Trials
  • Table 108: ThermoGenesis Corp. Pipeline Products By News Summary
  • Table 109: CSMG Technologies, Inc. Pipeline Products by Equipment Type
  • Table 110: CSMG Technologies, Inc. Pipeline Products By Development Stage
  • Table 111: CSMG Technologies, Inc. Pipeline Products By Therapy Area
  • Table 112: Applied Nanoscience Terminates Acquisition Of Emergency Filtration Products
  • Table 113: Moog Acquires Ethox International
  • Table 114: Johnson & Johnson Acquires Omrix Biopharmaceuticals
  • Table 115: Filtrona Acquires Lendell Manufacturing
  • Table 116: ACell Signs An Agreement With Medline Industries
  • Table 117: HyperBranch Medical Technology Enters Into An Agreement With BD
  • Table 118: Ivivi Technologies Signs An Agreement With Recovercare
  • Table 119: ConvaTec Enters Into An Agreement With Boehringer Wound Systems
  • Table 120: USD to Local Currency, Average Exchange Rate 2008
• 1.2 List of Figures
  • Figure 1: United States, Healthcare Expenditure by Source, 2003
  • Figure 2: United States, Healthcare Infrastructure, Top Level View, 2007
  • Figure 3: Healthcare Expenses Segmentation by End User, 2003
  • Figure 4: Medical Equipment Approval Process in the United States, 2007
  • Figure 5: PMA Approval Process in the United States, 2007
  • Figure 6: The 510(k) Approval Process for Medical Devices in the United States, 2007
  • Figure 7: Reimbursement Structure in the United States, 2007
  • Figure 8: Distribution Structure of Medical Equipment in the United States, 2006
  • Figure 9: Wound Care Management Cross Country Comparison, Revenue ($ mn), 2000-2015
  • Figure 10: Wound Care Management, United States, Overall Revenue ($ mn), 2000-2015
  • Figure 11: Wound Care Management, United States, Cross-Category Analysis, 2000-2015
  • Figure 12: Wound Care Management, United States, Overall Revenue ($ mn), Historic, 2000-2008
  • Figure 13: Wound Care Management, United States, Overall Revenue ($ mn), Forecast, 2008-2015
  • Figure 14: Wound Care Management, United States, Category Volume (Units), 2000-2015
  • Figure 15: Wound Care Management, United States, Category Volume (Units), Historic, 2000-2008
  • Figure 16: Wound Care Management, United States, Category Volume (Units), Forecast, 2008-2015
  • Figure 17: Wound Care Management, United States, Company Share (%), 2007
  • Figure 18: Advanced Wound Management, United States, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Figure 19: Advanced Wound Management, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Figure 20: Advanced Wound Management, United States, Volume (Units) by Segment, Historic, 2000-2008
  • Figure 21: Advanced Wound Management, United States, Volume (Units) by Segment, Forecast, 2008-2015
  • Figure 22: Advanced Wound Management, United States, Company Share (%), 2007
  • Figure 23: Compression Therapy, United States, Revenue ($ mn), Historic, 2000-2008
  • Figure 24: Compression Therapy, United States, Revenue ($ mn), Forecast, 2008-2015
  • Figure 25: Compression Therapy, United States, Volume (Units), Historic, 2000-2008
  • Figure 26: Compression Therapy, United States, Volume (Units), Forecast, 2008-2015
  • Figure 27: Compression Therapy, United States, Company Share (%), 2007
  • Figure 28: Ostomy, United States, Revenue ($ mn), Historic, 2000-2008
  • Figure 29: Ostomy, United States, Revenue ($ mn), Forecast, 2008-2015
  • Figure 30: Ostomy, United States, Volume (Units), Historic, 2000-2008
  • Figure 31: Ostomy, United States, Volume (Units), Forecast, 2008-2015
  • Figure 32: Ostomy, United States, Company Share (%), 2007
  • Figure 33: Traditional Wound Management, United States, Revenue ($ mn), Historic, 2000-2008
  • Figure 34: Traditional Wound Management, United States, Revenue ($ mn), Forecast, 2008-2015
  • Figure 35: Traditional Wound Management, United States, Volume (Units), Historic, 2000-2008
  • Figure 36: Traditional Wound Management, United States, Volume (Units), Forecast, 2008-2015
  • Figure 37: Traditional Wound Management, United States, Company Share (%), 2007
  • Figure 38: Wound Closure Devices, United States, Revenue ($ mn) by Segment, Historic, 2000-2008
  • Figure 39: Wound Closure Devices, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015
  • Figure 40: Wound Closure Devices, United States, Volume (Units) by Segment, Historic, 2000-2008
  • Figure 41: Wound Closure Devices, United States, Volume (Units) by Segment, Forecast, 2008-2015
  • Figure 42: Wound Closure Devices, United States, Company Share (%), 2007
  • Figure 43: Baxter International Inc. Value Chain Analysis
  • Figure 44: Covidien Ltd./Tyco Healthcare Value Chain Analysis
  • Figure 45: Smith & Nephew Plc Value Chain Analysis
  • Figure 46: Johnson & Johnson Value Chain Analysis
  • Figure 47: Coloplast A/S Value Chain Analysis
  • Figure 48: Kinetic Concepts, Inc. Value Chain Analysis
  • Figure 49: Advanced Medical Solutions Group Plc Value Chain Analysis
  • Figure 50: Hartmann Group Value Chain Analysis
  • Figure 51: Integra LifeSciences Holdings Corporation Value Chain Analysis
  • Figure 52: Global Markets Direct Methodology